Navigation Links
BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies

LUDWIGSHAFEN, Germany and ST. LOUIS, Jan. 20 /PRNewswire-FirstCall/ -- BASF and Monsanto Company (NYSE: MON) today announced a new joint-licensing agreement to accelerate the development of the next-generation of dicamba- based weed control chemistry products. Both parties will participate in the development of innovative formulations for dicamba for use with herbicide- resistant cropping systems. Further details of the agreement were not disclosed.

Researchers are able to make herbicide-resistant crops using plant biotechnology and advanced plant breeding to enable farmers to control weeds more efficiently and save time, money and fuel. Crops that are resistant to both Roundup(R) agricultural herbicides and dicamba would represent the next generation of herbicide-resistant crops to deliver significant on-farm benefits to growers. Improved formulations of dicamba are being developed to complement this new combination of herbicide-resistant crops.

"We are very excited to actively participate in developing innovative solutions for this next-generation cropping system for growers," said Emmanuel Butstraen, Group Vice President, Global Strategic Marketing, Herbicides, for BASF's Crop Protection division. BASF is currently the largest provider of dicamba and dicamba-based solutions.

BASF has a proven track record of bringing innovative formulation technologies to the market that improve the effectiveness and environmental profile of crop protection products. Later this year, it will launch its blockbuster herbicide Kixor(TM) in North America.

"Effective weed control is critical for increasing crop yields to meet the growing global demand for food, feed and fuel," said Sean Gardner, Monsanto's Global Chemistry lead. "Combining a second type of herbicide resistance with Roundup Ready(R) technology would offer growers multiple tools for weed control through the use of Roundup(R), dicamba, or combinations of both herbicides."

Monsanto is working to develop dicamba-resistant soybean and cotton products to combine with its current Roundup Ready(R) products. Both products would provide a new, unique way to control broadleaf weeds, designed to provide growers with an effective and high-yielding weed management system.

About Monsanto

Monsanto is an agriculture company. The company is a leading provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto is committed to investing in products that can make a difference for its farmer customers and the land they farm. The company uses plant breeding, plant biotechnology and other applications of modern science to support its commitment to agriculture and the farmers that feed, clothe and fuel our growing world. For more information on Monsanto, see

About BASF

With sales of euro 3,137 million in 2007, BASF's Crop Protection division is a leader in crop protection and a strong partner to the farming industry providing well-established and innovative fungicides, insecticides and herbicides. Farmers use these products and services to improve crop yields and crop quality. Other uses include public health, structural/urban pest control, turf and ornamental plants, vegetation management, and forestry. The vision of BASF's Crop Protection division is to be the world's leading innovator, optimizing agricultural production, improving nutrition, and thus enhancing the quality of life for a growing world population. Further information can be found on the web at

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF has more than 95,000 employees and posted sales of almost euro 58 billion in 2007. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at

Cautionary Statements Regarding Monsanto's Forward-Looking Information: Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

Note to Editor: Roundup and Roundup Ready are trademarks of Monsanto Company and its wholly owned subsidiaries. Kixor is a trademark of BASF.

SOURCE Monsanto Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Monsanto Shareowners Reelect Board Members at Companys Annual Meeting
2. Monsanto Board Approves 10 Percent Dividend Increase
3. Monsanto Recognized as Top Biotechnology Employer by Science Magazine
4. Monsanto Sees Growing Opportunity for Biotech Traits Globally
5. New Insect Protection Technology From Monsanto Company Deregulated by USDA
6. Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch
7. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
8. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
9. Monsanto Executives to Address Investor Conferences in February
10. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
11. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
Breaking Biology News(10 mins):